Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Blood (2022) 140 (6): 594–607.

https://doi.org/10.1182/blood.2021015220

Published: 2022

Includes: Supplemental data

Journal Articles

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Takashi Nagayama, MD, Shin-ichiro Fujiwara, MD PhD, Hirotomo Nakashima, MD, Shinichiro Kawaguchi, MD, Shoko Ito, MD, Kiyomi Mashima, MD, Kento Umino, MD, Daisuke Minakata, MD, Hirofumi Nakano, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Chihiro Yamamoto, MD PhD, Masahiro Ashizawa, MD, Kaoru Hatano, MD PhD, Kazuya Sato, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2019) 134 (Supplement_1): 5686.

https://doi.org/10.1182/blood-2019-122537

Published: 2019

Journal Articles

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Hirofumi Nakano, MD, Kazuya Sato, MD PhD, Hiroko Hayakawa, PhD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Kaoru Morita, MD PhD, Ryoko Yamasaki, MD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 3320.

https://doi.org/10.1182/blood-2018-99-110011

Published: 2018

Journal Articles

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Yasufumi Kawasaki, MD PhD, Kazuya Sato, MDPhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2018-99-111773

Published: 2018

Journal Articles

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Yasufumi Kawasaki, Kazuya Sato, MDPhD, Hiroko Hayakawa, PhD, Norihito Takayama, PhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MDPhD, Yoshinobu Kanda, MD PhD

Blood (2017) 130 (Supplement 1): 4441.

https://doi.org/10.1182/blood.V130.Suppl_1.4441.4441

Published: 2017

Journal Articles

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

Blood (2016) 128 (22): 3350.

https://doi.org/10.1182/blood.V128.22.3350.3350

Published: 2016

Journal Articles

Impact Of Systemic Antibiotic Prophylaxis In Hematopoietic Stem Cell Transplantation Recipients. A Meta-Analysis Of Randomized Controlled Trials

Shun-ichi Kimura, MD, Hiroshi Nakano, MD, Tomotaka Ugai, MD, Hidenori Wada, MD, Ryoko Yamasaki, MD, Yuko Ishihara, MD, Koji Kawamura, MD, Kana Sakamoto, MD, Masahiro Ashizawa, MD, Miki Sato, MD, Kiriko Terasako-Saito, MD, Hideki Nakasone, MD, Misato Kikuchi, MD, Shinichi Kako, MD, Junya Kanda, MD, Rie Yamazaki, MD, Aki Tanihara, Junji Nishida, MD, Yoshinobu Kanda, MD

Blood (2013) 122 (21): 4534.

https://doi.org/10.1182/blood.V122.21.4534.4534

Published: 2013

NARROW

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

Impact Of Systemic Antibiotic Prophylaxis In Hematopoietic Stem Cell Transplantation Recipients. A Meta-Analysis Of Randomized Controlled Trials

Email alerts

ASH Publications

American Society of Hematology

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

Impact Of Systemic Antibiotic Prophylaxis In Hematopoietic Stem Cell Transplantation Recipients. A Meta-Analysis Of Randomized Controlled Trials

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only